213 related articles for article (PubMed ID: 34885887)
21. A potential therapeutic agent for the treatment of hyperuricemia and gout: 3,4-Dihydroxy-5-nitrobenzaldehyde phenylthiosemicarbazide.
Yu X; Ren S; Zhou J; Liao Y; Huang Y; Dong H
Eur J Pharm Sci; 2024 Jul; 198():106778. PubMed ID: 38653341
[TBL] [Abstract][Full Text] [Related]
22. Essential oil from leaves of Cinnamomum osmophloeum acts as a xanthine oxidase inhibitor and reduces the serum uric acid levels in oxonate-induced mice.
Wang SY; Yang CW; Liao JW; Zhen WW; Chu FH; Chang ST
Phytomedicine; 2008 Nov; 15(11):940-5. PubMed ID: 18693097
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of xanthine oxidase inhibitory activity of flavonoids by an online capillary electrophoresis-based immobilized enzyme microreactor.
Wu ZY; Zhang H; Li F; Yang FQ
Electrophoresis; 2020 Aug; 41(15):1326-1332. PubMed ID: 32363581
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis and bioactive evaluation of geniposide derivatives for antihyperuricemic and nephroprotective effects.
Wang M; Chen J; Zhang R; Guo X; Chen D; Guo X; Chen Y; Wu Y; Sun J; Liu Y; Liu C
Bioorg Chem; 2021 Nov; 116():105321. PubMed ID: 34500305
[TBL] [Abstract][Full Text] [Related]
25. Discovery of digallic acid as XOD/URAT1 dual target inhibitor for the treatment of hyperuricemia.
Zheng F; Mai S; Cen X; Zhao P; Ye W; Ke J; Lin S; Hu H; Guo Z; Zhang S; Liao H; Wu T; Tian Y; Zhang Q; Pang J; Zhao Z
Bioorg Chem; 2024 Jun; 147():107381. PubMed ID: 38669781
[TBL] [Abstract][Full Text] [Related]
26. Anti-Hyperuricemic Effect of 2-Hydroxy-4-methoxy-benzophenone-5-sulfonic Acid in Hyperuricemic Mice through XOD.
Yong T; Li D; Li M; Liang D; Diao X; Deng C; Chen S; Xie Y; Chen D; Zuo D
Molecules; 2018 Oct; 23(10):. PubMed ID: 30336599
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of 1-alkyl-5/6-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-1H-indole-3-carbonitriles as novel xanthine oxidase inhibitors.
Gao J; Liu X; Zhang B; Mao Q; Zhang Z; Zou Q; Dai X; Wang S
Eur J Med Chem; 2020 Mar; 190():112077. PubMed ID: 32014678
[TBL] [Abstract][Full Text] [Related]
28. In silico design and synthesis of N-arylalkanyl 2-naphthamides as a new class of non-purine xanthine oxidase inhibitors.
Ho SL; Lin CT; Lee SS
Drug Dev Res; 2021 Sep; 82(6):789-801. PubMed ID: 33398913
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological evaluation of a novel skeleton compound isobavachin (4',7-dihydroxy-8-prenylflavanone) as a hypouricemic agent: Dual actions of URAT1/GLUT9 and xanthine oxidase inhibitory activity.
Zhao Z; Luo J; Liao H; Zheng F; Chen X; Luo J; Chen Y; Zhao K; Zhang S; Tian J; Wu T; Li Y; Li L; Yang Y; Lin C; Zhang Q; Tian Y; Pang J
Bioorg Chem; 2023 Apr; 133():106405. PubMed ID: 36753966
[TBL] [Abstract][Full Text] [Related]
30. Systematic investigation of the amino acid profiles that are correlated with xanthine oxidase inhibitory activity: Effects, mechanism and applications in protein source screening.
Huang Y; Fan S; Lu G; Sun N; Wang R; Lu C; Han J; Zhou J; Li Y; Ming T; Su X
Free Radic Biol Med; 2021 Dec; 177():326-336. PubMed ID: 34748910
[TBL] [Abstract][Full Text] [Related]
31. Antihyperuricemic effects of thiadiazolopyrimidin-5-one analogues in oxonate treated rats.
Sathisha KR; Gopal S; Rangappa KS
Eur J Pharmacol; 2016 Apr; 776():99-105. PubMed ID: 26875636
[TBL] [Abstract][Full Text] [Related]
32. Modified Chuanhu anti-gout mixture, a traditional Chinese medicine, protects against potassium oxonate-induced hyperuricemia and renal dysfunction in mice.
You W; Wang J; Zou Y; Che K; Hou X; Fei H; Wang Y
J Int Med Res; 2019 May; 47(5):1927-1935. PubMed ID: 30832523
[TBL] [Abstract][Full Text] [Related]
33. Actions of
Yong T; Chen S; Liang D; Zuo D; Diao X; Deng C; Wu Y; Hu H; Xie Y; Chen D
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340390
[No Abstract] [Full Text] [Related]
34. Isoorientin exerts a urate-lowering effect through inhibition of xanthine oxidase and regulation of the TLR4-NLRP3 inflammasome signaling pathway.
An MF; Wang MY; Shen C; Sun ZR; Zhao YL; Wang XJ; Sheng J
J Nat Med; 2021 Jan; 75(1):129-141. PubMed ID: 33188510
[TBL] [Abstract][Full Text] [Related]
35. Effects of extracts of leaves from Sparattosperma leucanthum on hyperuricemia and gouty arthritis.
Lemos Lima Rde C; Ferrari FC; de Souza MR; de Sá Pereira BM; de Paula CA; Saúde-Guimarães DA
J Ethnopharmacol; 2015 Feb; 161():194-9. PubMed ID: 25500302
[TBL] [Abstract][Full Text] [Related]
36. Effects of xanthine oxidase inhibitors on renal function and blood pressure in hypertensive patients with hyperuricemia.
Kohagura K; Tana T; Higa A; Yamazato M; Ishida A; Nagahama K; Sakima A; Iseki K; Ohya Y
Hypertens Res; 2016 Aug; 39(8):593-7. PubMed ID: 27075830
[TBL] [Abstract][Full Text] [Related]
37. Xanthine oxidase inhibitors from the leaves of Lagerstroemia speciosa (L.) Pers.
Unno T; Sugimoto A; Kakuda T
J Ethnopharmacol; 2004 Aug; 93(2-3):391-5. PubMed ID: 15234783
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory mechanism of xanthine oxidase activity by caffeoylquinic acids in vitro.
Wan Y; Qian J; Li Y; Shen Y; Chen Y; Fu G; Xie M
Int J Biol Macromol; 2021 Aug; 184():843-856. PubMed ID: 34146563
[TBL] [Abstract][Full Text] [Related]
39. A novel IgG1 monoclonal antibody against xanthine oxidase alleviates inflammation induced by potassium oxonate in mice.
Liu X; Li Y; Li Z; Wei X; Ma Y; Cheng P; Jiao R; Fang J; Xing Y; Tang J; Wang M; Li T
Int J Biol Macromol; 2018 Jun; 112():537-547. PubMed ID: 29382583
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and evaluation of hydroxychalcones as multifunctional non-purine xanthine oxidase inhibitors for the treatment of hyperuricemia.
Xie Z; Luo X; Zou Z; Zhang X; Huang F; Li R; Liao S; Liu Y
Bioorg Med Chem Lett; 2017 Aug; 27(15):3602-3606. PubMed ID: 28655421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
